Table 3 Proportion of patients receiving treatment within each regimen
| Â | MDS | MDNS | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Treatment | 1st | 2nd | 3rd | 4th | ≥ 5th | 1st | 2nd | 3rd | 4th | ≥ 5th |
Pharmacotherapy (n,%) | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
AD | 915 (36.48) | 270 (31.84) | 115 (23.52) | 42 (27.63) | 13 (21.67) | 796 (34.13) | 229 (29.93) | 91 (21.21) | 39 (25.32) | 9 (15.00) |
AD + AD | 203 (8.09) | 121 (14.27) | 84 (17.18) | 19 (12.50) | 9 (15.00) | 236 (10.12) | 104 (13.59) | 59 (13.75) | 18 (11.69) | 10 (16.67) |
AD + AP | 1021 (40.71) | 307 (36.20) | 203 (41.51) | 66 (43.42) | 24 (40.00) | 985 (42.24) | 295 (38.56) | 205 (47.79) | 66 (42.86) | 28 (46.67) |
AD + MS | 86 (3.43) | 25 (2.95) | 22 (4.50) | 3 (1.97) | 6 (10.00) | 58 (2.49) | 13 (1.70) | 10 (2.33) | 3 (1.95) | 4 (6.67) |
AD + MS + AP | 123 (4.90) | 50 (5.90) | 25 (5.11) | 12 (7.89) | 4 (6.67) | 88 (3.77) | 20 (2.61) | 18 (4.20) | 7 (4.55) | 1 (1.67) |
Others | 160 (6.38) | 75 (8.84) | 40 (8.18) | 10 (6.58) | 4 (6.67) | 169 (7.25) | 104 (13.59) | 46 (10.72) | 21 (13.64) | 8 (13.33) |
Physiotherapy (n, %) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
ECT | 2180 (52.90) | 2133 (51.76) | 1295 (31.42) | 533 (12.93) | 252 (6.12) | 1523 (39.89) | 1472 (38.55) | 906 (23.73) | 406 (10.63) | 190 (4.98) |